March 31, 2012 | Mark Paradies

QMN Weekly Bulletin Reports Bad Root Cause Analysis as One of the Most Common FDA Findings

A recent article about a drug manufacturer quality problem said:

Root cause analysis isn’t new, but it is one of the most often misunderstood quality processes drugmakers must master. In fact, inadequate root cause analysis is one of the FDA’s most common findings during an inspection.

It then says they can send you a booklet to learn how to perform root cause analysis.

A booklet? You must be kidding. For something as important as the pharmaceutical quality, would you depend on a booklet?

Why not check out the techniques used by industry leaders worldwide – TapRooT®.

For public course information, see:

Or drop us a note to set up a course at your site.

Root Cause Analysis
Show Comments

Leave a Reply

Your email address will not be published. Required fields are marked *